BlueCrest Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-24,800
| Closed | -$748K | – | 93 |
|
|
2025
Q1 | $748K | Sell |
24,800
-1,400
| -5% | -$42.2K | 0.03% | 46 |
|
|
2024
Q4 | $916K | Buy |
+26,200
| New | +$916K | 0.03% | 54 |
|
|
2019
Q2 | – | Sell |
-34,935
| Closed | -$2.84M | – | 731 |
|
|
2019
Q1 | $2.84M | Buy |
34,935
+15,092
| +76% | +$1.23M | 0.11% | 129 |
|
|
2018
Q4 | $1.07M | Buy |
19,843
+9,343
| +89% | +$505K | 0.06% | 194 |
|
|
2018
Q3 | $542K | Buy |
+10,500
| New | +$542K | 0.01% | 699 |
|
|
2017
Q3 | – | Sell |
-27,706
| Closed | -$1.41M | – | 942 |
|
|
2017
Q2 | $1.41M | Buy |
27,706
+16,215
| +141% | +$825K | 0.05% | 385 |
|
|
2017
Q1 | $462K | Buy |
11,491
+6,894
| +150% | +$277K | 0.02% | 430 |
|
|
2016
Q4 | $220K | Sell |
4,597
-9,211
| -67% | -$441K | 0.01% | 556 |
|
|
2016
Q3 | $506K | Buy |
+13,808
| New | +$506K | 0.02% | 490 |
|
|
2016
Q1 | – | Sell |
-14,633
| Closed | -$906K | – | 879 |
|
|
2015
Q4 | $906K | Buy |
+14,633
| New | +$906K | 0.04% | 410 |
|
|
2015
Q3 | – | Sell |
-17,414
| Closed | -$1M | – | 856 |
|
|
2015
Q2 | $1M | Buy |
+17,414
| New | +$1M | 0.03% | 432 |
|
|
2015
Q1 | – | Sell |
-4,387
| Closed | -$271K | – | 636 |
|
|
2014
Q4 | $271K | Buy |
+4,387
| New | +$271K | 0.01% | 456 |
|